Nipro Glass
February 10, 2012
OSAKA, JAPAN – February 10, 2012 – Nipro Corporation (Head Office: Osaka, Japan) announced today the completion of the acquisition of the Liebmann Group, Münnerstadt, Germany.
The acquisition of the Liebmann Group, known commercially as MGlas AG and MG STERILE PRODUCTS AG is part of Nipro’s strategy to develop its glass business internationally. In addition to a regional expansion, the acquisition allows for a significant portfolio expansion. The Liebmann Group brings state-of-the-art sterile and non-sterile pharmaceutical glass packaging, including syringe manufacturing, to the European glass activities of Nipro.
Click here for the official press release.
Nipro Diabetes Care
January 31, 2011
(Fort Lauderdale, FL) – Nipro Diagnostics, Inc. has won the Manufacturers Association of Florida (MAF) 2011 Manufacturer of the Year Award. The company was recognized in the large-company (500+ employees) category. The award, based on evaluation of leading-edge management practices, manufacturing and process quality, and other performance-excellence criteria, was presented at the 2011 MAF Manufacturers Summit & Marketplace award ceremony on December 1, 2011
Click here for the official press release
Nipro Glass
July 27, 2011
OSAKA, JAPAN – July 27, 2011 – Nipro Corporation (Head Office: Osaka, Japan) announced today the completion of the previously announced pending acquisition of Amcor Glass Tubing, a division of Amcor. (Head Office: Hawthorn, Australia)
The acquisition of Amcor Glass Tubing is part of Nipro’s strategy to develop its glass business internationally. In addition to a regional expansion, the acquisition allows for a significant portfolio expansion.
The combined organizations will now cover all major global markets with a qualitative offer adapted to local demands.
Kurt van Dal, current President and CEO of Nipro Europe, has been given the additional role of President and CEO of the new organizations; Nipro Glass Americas, Nipro Glass Belgium and Nipro Glass France. The global headquarters will be located in Brussels, Belgium.
“We are very excited to be able to serve our customers in the global glass market” said Mr. Van Dal. “The Nipro Glass organizations are built on qualitative products and skilled people. This, in combination with our expertise and existing network of customers will make us a strong player and undisputedly a challenger for the market leaders.”
The financials of Amcor Glass Tubing will be included on the balance sheet and profits and losses of Nipro Corporation on consolidated basis, starting September 1st, 2011.
About Nipro Corporation:
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), founded in 1954, is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-relates products. Nipro’s pharmaceutical division is engaged in the research, manufacture and sale of pharmaceuticals, such as blood derivatives. The instrument division of Nipro manufactures and sells glass pipes and other glass products, including the inner bottles of thermos bottles. Nipro and its subsidiaries also sell medical device manufacturing equipment and conduct real estate leasing and non-life insurance agency businesses. For more information please visit www.nipro.co.jp
Japanese Earthquake – Update (3)
April 7, 2011
Nipro Japan has started monitoring radiation levels in tap water, on the manufacturing grounds, raw materials and even incoming inner boxes and shipping cartons. At Nipro Europe’s side, we have an agreement with the SCK-CEN (Belgian nuclear energy study center) to sample test incoming goods upon arrival in Europe on the presence of radioactive material. So far, and as expected, these measurements show no abnormal values.
Japanese Earthquake – Update (2)
March 18, 2011
Several sources, including the Tokyo Metropolitan Government, say radiation levels in Tokyo are dropping to normal background levels. Our dialyzer manufacturing facilities are located almost twice as far from Fukushima than Tokyo.
Our staff on-site has resumed work as usual.
Japanese Earthquake – Update (1)
March 17, 2011
We keep receiving reassuring messages from our manufacturing plants in Japan. Earthquake damages have been repaired and production has been restored. Also, all our plants exporting to Europe are well out of the zone potentially affected by the current nuclear fall-out from Fukushima. Please visit this web-site for future updates.
Japanese Earthquake
March 11, 2011
Today, the north-east of Japan was struck by an earthquake with a force of 8.9, triggering a Tsunami. There are alarming reports of destruction and damages in the North East, especially due to the Tsunami.
Nipro Japan has its headquarter in Osaka and 2 main production facilities in Odate and Tatebayashi. We have received information from them that there are no structural damages or personal injuries. Our Nipro colleagues are quite impressed by it all, but they assured us that they will continue their normal work and production schedule.
Our thoughts go out to all those that were affected.
SureFuser™+ Test Report
January 24, 2011
Nipro just released a scientific report performed by an independant laboratory in France regarding the infusion time and flowrate (ISO 28620).
You can download the file here. Or go to our SureFuser page for more information
Phoenix Water Systems
October 1, 2010
Nipro Europe has joined up with Phoenix Pure Water GmbH to complete their product range within Renal Care.
Phoenix Pure Water a German company, specialized in watertreatment systems for dialysis centers.
Diabetes Care
February 3, 2010
Nipro recently acquired Home Diagnostics Inc., now Nipro Diagnostics Inc.
Home Diagnostic was specialized in glucose meters for diabetes.
Nipro Europe will promote their product range under the product group Diabetes Care.
